hims novo nordisk - Search News

Hims & Hers shares surge

Hims & Hers shares surge after Novo Nordisk drops patent infringement case over compounded weight loss drugs

Novo dropped its patent-infringement case against telehealth provider Hims & Hers after the companies agreed that Hims would sell Novo's branded medicines.

· 1d · on MSN

Novo Nordisk to sell weight-loss drugs through Hims & Hers

· 16h · on MSN

Hims & Hers stock skyrockets 40% as Novo Nordisk ends feud, agrees to sell Ozempic and Wegovy on platform

43m

Asset Manager Exits Shares of Hims & Hers Health

On February 17, 2026, BLKBRD Asset Management, LP, disclosed it sold out its entire stake in Hims & Hers Health (HIMS +5.89%), an estimated $18.07 million trade based on quarterly ...

1don MSN

Hims & Hers Shares Double on Report of Wegovy Tie-Up

Stock skyrocketed premarket following a media report that the maker of Wegovy plans to sell the weight-loss drug on the Hims ...

Novo Nordisk Targets Obesity Edges With Irish Spend And Hims Alliance

Novo Nordisk (CPSE:NOVO B) is committing €432 million to expand its oral GLP-1 manufacturing facility in Ireland, aimed at supporting future products and supply outside the US. The company has settled ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results